Astraveus raised €17M in a Seed round in Jun 2023. The company is based in Paris, France. Investors in the round: AdBio partners, Bpifrance, JJDC – Johnson & Johnson's fund and 1 other. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €17M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.